The table below shows Atea Pharmaceuticals, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
-
$351.37M
$48.63M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$148.02M
$144.10M
$114.24M
$81.94M
$167.21M
$38.02M
SG&A
$32.86M
AVIR annual revenue (10-K history)
Atea Pharmaceuticals, Inc. reported annual revenue of $351.37M for fiscal year 2021. That is up 622.5% from $48.63M in fiscal 2020. Figures come from the company's audited annual reports as filed with the SEC.